Trial intelligence / Profile preview

Double Umbilical Cord Blood Transplantation in Hematological Malignancies

NCT00763490Phase 2Completed

Sponsor
University of Michigan Rogel Cancer Center
Start
Dec 2008
Primary completion
Mar 2013
Modality
Hematopoietic Stem Cells
Countries
1
01

Overview

A Phase 2 trial of umbilical cord blood in hematological malignancy, sponsored by University of Michigan Rogel Cancer Center. Started Dec 2008; status: completed.

02

Drugs

umbilical cord blood
03

Conditions

hematological malignancy

Beyond the preview

Go deeper on NCT00763490.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00763490.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call